GlassScriptPhysician profile
Alexandra Ward
NPI 1548536451
$18,453.28
in general payments reported to CMS, 2019-2025
17 companies · $1,271 in 2025
The $1,271 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $417 · 2021: $4,348 · 2022: $4,665 · 2023: $5,499 · 2024: $1,963 · 2025: $1,271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Travel and Lodging: $2,934 · Food and Beverage: $1,299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Travel and Lodging | $2,934.22 |
| Food and Beverage | $1,299.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15,582.89 | 2020-2024 | Lifevest |
| Abbott Laboratories | $1,462.19 | 2023-2025 | Triclip, Mitraclip |
| Abiomed | $545.07 | 2019-2023 | Impella |
| Biotronik INC. | $213.70 | 2020-2021 | |
| Akcea Therapeutics, INC. | $125.00 | 2019 | |
| Eko Health, INC. | $116.92 | 2024 | |
| Edwards Lifesciences Corporation | $71.31 | 2023-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amgen INC. | $55.19 | 2019-2023 | Repatha |
| Regeneron Healthcare Solutions, INC. | $48.45 | 2019 | |
| Janssen Pharmaceuticals, INC | $46.13 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $40.88 | 2024-2025 | |
| Pfizer INC. | $36.32 | 2020-2025 | |
| Boston Scientific Corporation | $26.18 | 2022 | |
| Philips North America LLC | $24.35 | 2024 | (Cm9) Amb Mon & Diag Und |
| W. L. Gore & Associates, INC. | $21.94 | 2023 | Gore Cardioform Septal Occluder |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $21.15 | 2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $15.61 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.